Lung Caner

In China, Taiwan and around the world, lung cancer deaths are the main reason. At present, China is the world's first lung power, if not effectively controlled, lung cancer patients in China is expected to reach one million in 2025. Since China and Taiwan lung cancer patients are HPV (+) ratio is relatively higher than other countries. GBP will be a priority in this year's independent development ADXS-HPV vaccine to treat HPV (+) patients with lung cancer.